top of page
Abstract Dot Pattern

SCIENCE & RESEARCH

For Cancer Survivors

AB-Free Kava and Cancer Prevention

Epidemiological data indicate the potential of kava to reduce cancer risks (23).

AB-Free Kava cancer prevention in preclinical animal models against lung, prostate, and colon tumorigenesis (5, 13, 14).

A pilot single-arm trial demonstrated the potential to reduce biomarkers associated with lung cancer risk (19, 24).

A pilot double-blind, placebo-controlled randomized trial (NCT05081882) is evaluating safety and lung cancer risk biomarker reduction, with a manuscript in preparation.

Epidemiological or historical data – a brief synoposis with potentially figures and a click to the corresponding site or reference

Clinical data – a brief synoposis with potentially figures and a click to the corresponding site or reference (JEK trial) with a cancer survivor trial at UMN and an expanded lung cancer risk trial at UF

Pre-clinical data – a brief synoposis with potentially figures and a click to the corresponding site or reference (lung, prostate and colon) from four different universities (UMN, UF, Texas Tech University, and Stony Brook University)

kava plant.avif

AB-Free Kava and Cancer Prevention (cancer warriors, cancer champions or cancer thrivers)

  • Kava epidemiological data, indicating the potential of kava to reduce cancer risks (23)
     

  • AB-free kava cancer prevention in preclinical animal models against lung, prostate, and colon tumorigenesis in pre-clinical animal models (5, 13, 14)
     

  • ​Pilot single-arm trial, demonstrating its potential to reduce biomarkers associated with lung cancer risk (9, 24)
     

  • Pilot double-blind placebo controlled randomized trial (21) with a manuscript in preparation regarding its safety and lung cancer risk biomarker reduction. (NCT05081882).
     

  • Dose and regimen: more is not always good

bottom of page